Related Experiment Video
Updated: May 26, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS
A Kerbrat1, B Aubert-Broche, V Fonov
1McConnell Brain Imaging Center , Montreal Neurological Institute, McGill University, Montreal, Canada.
Insights
Pediatric multiple sclerosis (MS) is linked to smaller head and brain sizes, with even greater reductions in thalamic volume compared to healthy children. This highlights significant early brain development impacts in pediatric MS.
Area of Science:
- Neurology
- Pediatric Medicine
- Neuroimaging
Background:
- Pediatric-onset multiple sclerosis (MS) can impact brain development.
- Understanding structural brain changes in pediatric MS is crucial for prognosis and management.
Purpose of the Study:
- To quantify white matter, gray matter, and deep gray matter volumes in pediatric MS patients.
- To compare brain structure volumes between pediatric MS patients and healthy controls.
Main Methods:
- Utilized MRI to measure intracranial volume, normalized brain volume, and regional deep gray matter volumes (thalamus, globus pallidus, putamen, caudate).
- Compared 38 pediatric MS patients with 33 age- and sex-matched healthy controls (HCs).
- Normalized volume measurements using z scores derived from a normative dataset of healthy children.
Main Results:
- Pediatric MS patients exhibited significantly lower intracranial volume z scores compared to HCs.
- Normalized brain volume z scores were significantly decreased in MS patients.
- Thalamic volumes remained significantly lower in MS patients even after correction for global brain volume, indicating disproportionate thalamic tissue loss.
- T2 lesion load and disease duration correlated with reduced normalized brain and thalamic volumes.
Conclusions:
- Childhood-onset MS is associated with smaller overall head size and brain volume.
- Thalamic volume is disproportionately reduced in pediatric MS patients compared to controls.
- These findings suggest early and significant structural brain alterations in pediatric MS.
Objective:
Whole brain and regional volume measurement methods were used to quantify white matter, gray matter, and deep gray matter structure volumes in a population of patients with pediatric-onset multiple sclerosis (MS).
Methods:
Subjects included 38 patients (mean age 15.2 ± 2.4 years) and 33 age- and sex-matched healthy control (HC) participants. MRI measures included intracranial volume, normalized brain volume, normalized white and gray matter volume, and volumes of the thalamus, globus pallidus, putamen, and caudate. Because these volumes vary across age and sex in children, we normalized the volume measurements for MS and control groups by computing z scores using normative values obtained from healthy children enrolled in the MRI Study of Normal Brain Development.
Results:
The intracranial volume z score was significantly lower in the patients with MS (-0.45 ± 1.16; mean ± SD) compared with the HC participants (+0.25 ± 0.98; p = 0.01). Patients with MS also demonstrated significant decreases in normalized brain volume z scores (-1.09 ± 1.49 vs -0.05 ± 1.22; p = 0.002). After correction for global brain volume, thalamic volumes in the MS population remained lower than those of HCs (-0.68 ± 1.72 vs 0.15 ± 1.35; p = 0.02), indicating an even greater loss of thalamic tissue relative to more global brain measures. Moderate correlations were found between T2-weighted lesion load and normalized thalamic volumes (r = -0.44, p < 0.01) and normalized brain volume (r = -0.47, p < 0.01) and between disease duration and normalized thalamic volume (r = -0.58, p < 0.001) and normalized brain volume (r = -0.46, p < 0.01).
Conclusions:
When compared with age- and sex-matched control subjects, the onset of MS during childhood is associated with a smaller overall head size, brain volume, and an even smaller thalamic volume.
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer Disease ll: Pathophysiology

